Covid Antiviral Therapy

Access to treatments for COVID-19 – changes from 27 June 2023

NHS England has written to the majority of patients who are currently eligible for treatments for COVID-19, to inform them the way they access these treatments is changing.

From Tuesday 27 June, eligible patients will be able to self-refer to the COVID Medicines Delivery Unit (CMDU), which provides antiviral medicines to patients who have tested positive for COVID-19 and who identify as belonging to the highest risk clinical subgroup.

This includes some patients with cancer, blood conditions, kidney disease, liver disease and auto-immune diseases, among others.

If you are an eligible patient and test positive for COVID-19, please contact the CMDU directly and self-refer by:

– Visiting online and completing a self-referral form

– Phoning 03300 587080

Patients will be assessed within 24 hours of referral.

Further information is available online: